Sensorimotor outcomes in adrenomyeloneuropathy show significant disease progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sensorimotor outcomes in adrenomyeloneuropathy show significant disease progression

Published:2021-12-09 Issue: Volume: Page:
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:Jrnl of Inher Metab Disea

Author:

Keller Jennifer L.¹,Eloyan Ani²,Raymond Gerald V.¹³⁴,Fatemi Ali¹⁴,Zackowski Kathleen M.¹⁴⁵

Affiliation:

1. Kennedy Krieger Institute Baltimore Maryland USA

2. Department of Biostatistics, School of Public Health Brown University Providence Rhode Island USA

3. Department of Genetic Medicine Johns Hopkins School of Medicine Baltimore Maryland USA

4. Department of Neurology Johns Hopkins School of Medicine Baltimore Maryland USA

5. Department of Physical Medicine and Rehabilitation Johns Hopkins School of Medicine Baltimore Maryland USA

Funder

U.S. Food and Drug Administration

National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jimd.12457

Reference25 articles.

1. X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies

2. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening

3. Sensorimotor Function and Axonal Integrity in Adrenomyeloneuropathy

4. Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International validation of meaningfulness of postural sway and gait to assess myeloneuropathy in adults with adrenoleukodystrophy;Journal of Inherited Metabolic Disease;2024-05-25

2. Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial;The Lancet Neurology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3